Clinical Trial: Post Authorisation Safety Study With Raxone in LHON Patients

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber's Hereditary Optic Neuropathy (LHON)

Brief Summary:

This study is a multicentre, prospective, non-interventional post-authorisation safety study (PASS) of the clinical outcomes for patients with LHON treated with Raxone®.

No medication will be provided as part of this study. Raxone® will be obtained through commercial channels.